Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:CRY

CryoLife (CRY) Stock Price, News & Analysis

CryoLife logo

About CryoLife Stock (NYSE:CRY)

Key Stats

Today's Range
N/A
50-Day Range
$17.19
$21.72
52-Week Range
N/A
Volume
7,792 shs
Average Volume
198,221 shs
Market Capitalization
$703.22 million
P/E Ratio
596.20
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

CryoLife Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
26th Percentile Overall Score

CRY MarketRank™: 

CryoLife scored higher than 26% of companies evaluated by MarketBeat, and ranked 844th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CryoLife.

  • Earnings Growth

    Earnings for CryoLife are expected to grow by 600.00% in the coming year, from $0.03 to $0.21 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CryoLife is 596.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 127.28.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CryoLife is 596.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 95.12.

  • Short Interest

    There is no current short interest data available for CRY.
  • Dividend Yield

    CryoLife does not currently pay a dividend.

  • Dividend Growth

    CryoLife does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CRY.
  • Search Interest

    2 people have searched for CRY on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CryoLife insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.50% of the stock of CryoLife is held by insiders.

  • Percentage Held by Institutions

    81.57% of the stock of CryoLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CryoLife's insider trading history.
Receive CRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CryoLife and its competitors with MarketBeat's FREE daily newsletter.

CRY Stock News Headlines

Artivion price target raised to $35 from $32 at Lake Street
Download Our Tesla Ebook For Free
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
Artivion (AORT) Receives a Buy from Lake Street
Can Artivion's Strong Vital Signs Lead To Further Stock Gains?
See More Headlines

CRY Stock Analysis - Frequently Asked Questions

CryoLife, Inc. (NYSE:CRY) released its quarterly earnings results on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.22. The medical equipment provider earned $72.21 million during the quarter, compared to analysts' expectations of $72.90 million. CryoLife had a trailing twelve-month return on equity of 4.24% and a net margin of 0.63%.

CryoLife subsidiaries include these companies: JOTEC AG, On-X Life Technologies Inc., Hemosphere, Cardiogenesis Corporation, AuraZyme Pharmaceuticals Inc., CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoLife investors own include Energy Transfer (ET), Johnson & Johnson (JNJ), AT&T (T), Meta Platforms (META), Gilead Sciences (GILD), International Business Machines (IBM) and Netflix (NFLX).

Company Calendar

Last Earnings
11/04/2021
Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
CUSIP
22890310
Employees
1,200
Year Founded
1984

Profitability

Net Income
$-16,680,000.00
Pretax Margin
0.41%

Debt

Sales & Book Value

Annual Sales
$253.23 million
Book Value
$8.46 per share

Miscellaneous

Free Float
37,560,000
Market Cap
$703.22 million
Optionable
Optionable
Beta
1.53

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:CRY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners